Cytosorbents (CTSO) Net Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,854.00 |
| Dec 31, 2025 | -5,386.00 |
| Sep 30, 2025 | -2,546.00 |
| Jun 30, 2025 | 4,952.00 |
| Mar 31, 2025 | 2,271.00 |
| Dec 31, 2024 | -2,954.00 |
| Sep 30, 2024 | 8,082.00 |
| Jun 30, 2024 | 835.00 |
| Mar 31, 2024 | 2,335.00 |
| Dec 31, 2023 | 2,154.00 |
| Sep 30, 2023 | -5,202.00 |
| Jun 30, 2023 | 3,583.00 |
| Mar 31, 2023 | -1,697.00 |
| Dec 31, 2022 | 5,957.00 |
| Sep 30, 2022 | -9,670.00 |
| Jun 30, 2022 | -7,000.00 |
| Mar 31, 2022 | -5,419.00 |
| Dec 31, 2021 | 7,278.00 |
| Sep 30, 2021 | 2,509.00 |
| Jun 30, 2021 | 8,775.00 |
| Mar 31, 2021 | 6,313.00 |
| Dec 31, 2020 | 13,797.00 |
| Sep 30, 2020 | 14,655.00 |
| Jun 30, 2020 | 19,507.00 |
| Mar 31, 2020 | 33,500.00 |
| Dec 31, 2019 | 114,771.00 |
| Sep 30, 2019 | 12,616.00 |
| Jun 30, 2019 | 25,810.00 |
| Mar 31, 2019 | 10,266.00 |
| Dec 31, 2018 | -1,906.00 |
| Sep 30, 2018 | 16,772.00 |
| Jun 30, 2018 | 148,633.00 |
| Mar 31, 2018 | 119,747.00 |
| Dec 31, 2017 | 127,173.00 |
| Sep 30, 2017 | 931,616.00 |
| Jun 30, 2017 | 319,097.00 |
| Mar 31, 2017 | 411,324.00 |
| Dec 31, 2016 | 518,923.00 |